In this Issue:
Predictors of HBsAg clearance
SVR12 defines “cure” rates in sofosbuvir-based regimes
Genotypic resistance data related to sofosbuvir
Serum HBV RNA levels predict HBeAg seroconversion?
Statins for preventing liver disease progression?
PegIFNα/ribavirin/PI in HCV-associated MC vasculitis
Avoid telbivudine + PegIFN in chronic HBV
Quantitative HBsAg kinetics and treatment response in chronic HBV
HBV envelope-expressing DNA vaccine disappoints
Preventing HBV reactivation in HBsAg+ patients on R-CHOP chemotherapy
Please login below to download this issue (PDF)